Bitcoin and Weed: Have the 2 Hottest Stories of the Past Decade Fizzled Out?

Bitcoin and the Aurora Cannabis stock suffered similar fates towards the end of the decade. It seems only a miracle can save their respective industries to rebound in 2020 and beyond.

| More on:
question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The investment world had two hottest stories in the last decade. There was too much hype surrounding cryptocurrencies and cannabis stocks. Investors were hungry for massive gains, thinking that the assets can live up to promise.

Rather than filling their pockets, many investors lost vast sums of money in both. My particular focus is on the rise and fall of Bitcoin (BTC) and Aurora Cannabis (TSX:ACB)(NYSE:ACB). The former is the top digital currency, while the latter is the largest cannabis producer.

Speculators’ choice

Many speculators, as well as thieves, made a fortune out of Bitcoin. The most prominent digital token featured a wild technology that raised investor enthusiasm. Based on data from Bloomberg, Bitcoin posted gains of nine million percent since July 2010.

Bitcoin was a virtual unknown until its launching in 2008 by a mysterious person by the name of Satoshi Nakamoto. The method of exchange between users was electronic, but the network lacks centralized control. Only computers keep track of transactions on the blockchain ledger.

The first transaction happened two years after its launching. Bitcoin’s value doubled several times. Investors saw a way to get-rich-quick despite warnings from financial institutions and several noted investors. Over the past 10 years, its run-up was huge until the mega-crash happened.

Investors’ insanity over Bitcoin was unprecedented. The peak price was $20,000 in late 2017 before crashing sharply to $3,000 by the end of 2018. Bitcoin’s problem is acceptance, adoption, and recognition as a new medium of exchange.

As it enters a new phase of growth, proponents are still hopeful that a large-scale embrace is forthcoming.

Up in smoke

The marijuana craze reached a fever-pitch a few months before Canada legalized recreational marijuana on October 17, 2018. Aurora Cannabis was in a position to be the industry leader because of its potential annual production capacity of 625,000 kilograms.

ACB was trading at $9.28 in early July 2018 before peaking to $15.07 on October 15, 2018. After the legalization, the price started to drop and sank as low as $6.68 on January 9, 2019. As of this writing, Aurora Cannabis is trading at $2.60.

A series of unfortunate events occurred in the cannabis sector. The industry-wide sell-off began in April 2019. Instead of a marijuana boom, 2019 became a brutal year for weed stocks.

Unlike other industry rivals, Aurora Cannabis has no big-name backer to this day. Only strategic advisor Nelson Peltz is helping the company strike partnerships. This weed stock is already trading at a deep discount and could not afford to fall further.

Its net debt of $618 million as of September 30, 2019, is almost double the company’s annualized sales. Some analysts see the need to hire a new CEO to bolster its credibility. The danger is that Aurora Cannabis might not have sufficient funds to get through 2020.

Bleak outlook

The hottest stories of the decade ended in tragedies both for the industry and investors. Investing in cryptocurrencies like Bitcoin is very risky, while no one dares touch weed stocks like Aurora Cannabis with a 10-foot pole.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »